Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Amgen hands back heart failure programme rights to Cytokinetics

pharmatimesNovember 25, 2020

Tag: Amgen , omecamtiv mecarbil , AMG 594 , GALACTIC-HF , Heart failure

PharmaSources Customer Service